Lifestance Health (LFST)

Nasdaq Health Care Health Care Services S&P SmallCap 600

$13.77

+0.34 (+2.53%)

Close of Nov 06, 2026 · end-of-day data

Source: Lifestance Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$212.52M	$1.45M	$859.54M	$1.06B	$1.25B	$1.42B
Selling, general & admin	$41.06M	$433.73M	$377.99M	$410.79M	$363.06M	$382.20M
Operating income	$15.24M	-$286.35M	-$210.17M	-$189.13M	-$31.61M	$24.15M
Interest expense	$5.41M	$38.91M	$19.93M	$21.22M	$26.54M	$11.66M
Pre-tax income	$7.88M	-$333.11M	-$232.73M	-$206.58M	-$57.61M	$12.36M
Income tax	$2.21M	-$25.91M	-$17.17M	-$20.32M	-$170.00K	$2.70M
Net income	$5.67M	-$307.20M	-$215.56M	-$186.26M	-$57.44M	$9.66M
EBITDA	$18.28M	-$271.26M	-$181.26M	-$151.76M	$9.06M	$65.77M
Diluted shares	—	327.52K	355.28M	367.46M	379.15M	391.14M
Operating margin	7.2%	-19816.8%	-24.5%	-17.9%	-2.5%	1.7%
Net margin	2.7%	-21259.3%	-25.1%	-17.6%	-4.6%	0.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$3.48M	$148.03M	$108.62M	$78.82M	$154.57M	$248.64M
Receivables	—	$76.08M	$100.87M	$125.41M	$131.80M	$95.71M
Total current assets	—	$266.52M	$233.22M	$225.73M	$312.51M	$416.20M
Goodwill	—	$1.20B	$1.27B	$1.29B	$1.29B	$1.29B
Total assets	—	$1.93B	$2.17B	$2.11B	$2.12B	$2.20B
Total current liabilities	—	$116.75M	$176.00M	$202.87M	$228.89M	$251.96M
Short-term debt	—	$1.32M	$2.35M	$2.92M	$7.25M	$14.50M
Long-term debt	—	$157.42M	$225.08M	$280.29M	$279.79M	$265.93M
Total debt	—	$158.74M	$227.42M	$283.21M	$287.04M	$280.43M
Total liabilities	—	$382.08M	$655.15M	$681.04M	$672.01M	$682.92M
Shareholders' equity	-$166.35M	$1.55B	$1.52B	$1.43B	$1.45B	$1.52B

Cash flow

fiscal years · USD

Fiscal year	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$17.05M	$9.42M	$52.79M	-$16.88M	$107.26M	$146.15M
Capital expenditures	$14.31M	$94.49M	$79.25M	$40.52M	$21.57M	$36.12M
Free cash flow	$2.73M	-$85.07M	-$26.47M	-$57.40M	$85.69M	$110.03M
Investing cash flow	-$73.38M	-$194.08M	-$139.46M	-$60.34M	-$21.57M	-$36.12M
Financing cash flow	$48.46M	$313.86M	$47.26M	$47.43M	-$9.95M	-$15.96M
Stock-based compensation	$54.00K	$259.44M	$187.43M	$99.39M	$76.17M	$74.70M
Depreciation & amortization	$3.04M	$15.09M	$28.92M	$37.37M	$40.68M	$41.62M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$280.60M	$300.44M	$312.33M	$312.72M	$325.48M	$332.97M	$345.31M	$363.81M	$382.19M	$403.48M	$435.35M	$455.86M
Selling, general & admin	$93.37M	$88.93M	$95.15M	$85.27M	$93.71M	$94.43M	$97.38M	$95.61M	$94.78M	$100.33M	$108.14M	$113.39M
Operating income	-$32.27M	-$16.77M	-$15.95M	$47.00K	$1.06M	$1.60M	-$2.95M	$7.41M	$18.08M	$22.28M	$30.65M	$33.08M
Interest expense	$5.53M	$5.90M	$5.82M	$5.41M	$9.40M	$3.07M	$2.90M	$2.81M	$2.88M	$1.79M	$2.63M	$2.49M
Pre-tax income	-$38.32M	-$20.73M	-$22.62M	-$5.38M	-$8.88M	-$1.47M	-$5.94M	$4.57M	$15.20M	$19.76M	$27.46M	$27.40M
Income tax	$6.64M	$363.00K	$656.00K	$575.00K	-$1.76M	-$2.18M	-$2.15M	$3.50M	$3.54M	$5.52M	$3.85M	$5.02M
Net income	-$44.96M	-$21.10M	-$23.28M	$709.00K	-$7.11M	$709.00K	-$3.79M	$1.08M	$11.67M	$14.24M	$23.61M	$22.39M
EBITDA	-$22.60M	-$6.75M	-$5.82M	$10.46M	$11.18M	$11.89M	$7.69M	$17.75M	$28.43M	$32.65M	$41.96M	$45.13M
Diluted shares	1.90M	376.33M	379.43M	380.36M	434.00K	390.67M	386.73M	388.89M	5.46M	395.08M	387.30M	391.22M
Operating margin	-11.5%	-5.6%	-5.1%	0.0%	0.3%	0.5%	-0.9%	2.0%	4.7%	5.5%	7.0%	7.3%
Net margin	-16.0%	-7.0%	-7.5%	0.2%	-2.2%	0.2%	-1.1%	0.3%	3.1%	3.5%	5.4%	4.9%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$78.82M	$49.45M	$86.97M	$102.61M	$154.57M	$134.34M	$188.93M	$203.90M	$248.64M	$194.80M	$225.94M	$218.82M
Receivables	$125.41M	$175.94M	$167.22M	$158.16M	$131.80M	$140.37M	$129.48M	$121.07M	$95.71M	$122.92M	$110.96M	$120.94M
Total current assets	$225.73M	$244.12M	$277.75M	$287.02M	$312.51M	$304.63M	$358.85M	$360.38M	$416.20M	$355.91M	$377.97M	$376.78M
Goodwill	$1.29B	$1.29B	$1.29B	$1.29B	$1.29B	$1.29B	$1.29B	$1.29B	$1.29B	$1.30B	$1.30B	$1.31B
Total assets	$2.11B	$2.11B	$2.12B	$2.11B	$2.12B	$2.10B	$2.15B	$2.15B	$2.20B	$2.15B	$2.18B	$2.19B
Total current liabilities	$202.87M	$207.46M	$227.66M	$217.51M	$228.89M	$207.38M	$242.28M	$228.56M	$251.96M	$239.73M	$274.75M	$261.13M
Short-term debt	$2.92M	$2.92M	$2.92M	$2.92M	$7.25M	$9.06M	$10.88M	$12.69M	$14.50M	$18.12M	$14.50M	$14.50M
Long-term debt	$280.29M	$279.87M	$279.46M	$279.06M	$279.79M	$276.32M	$272.86M	$269.39M	$265.93M	$262.46M	$258.99M	$255.52M
Total debt	$283.21M	$282.80M	$282.38M	$281.98M	$287.04M	$285.38M	$283.73M	$282.08M	$280.43M	$280.58M	$273.49M	$270.02M
Total liabilities	$681.04M	$677.32M	$689.32M	$670.85M	$672.01M	$647.57M	$672.88M	$656.23M	$682.92M	$668.47M	$704.35M	$693.89M
Shareholders' equity	$1.43B	$1.43B	$1.43B	$1.44B	$1.45B	$1.46B	$1.47B	$1.49B	$1.52B	$1.48B	$1.48B	$1.49B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$16.80M	-$21.84M	$44.06M	$22.72M	$62.32M	-$3.09M	$64.40M	$27.29M	$57.56M	$33.11M	$99.91M	$37.02M
Capital expenditures	$11.41M	$5.10M	$5.11M	$5.05M	$6.30M	$7.17M	$7.75M	$10.29M	$10.91M	$10.77M	$11.99M	$14.65M
Free cash flow	$5.38M	-$26.94M	$38.95M	$17.67M	$56.02M	-$10.26M	$56.64M	$17.00M	$46.65M	$22.34M	$87.92M	$22.36M
Investing cash flow	-$11.41M	-$5.10M	-$5.11M	-$5.05M	-$6.30M	-$7.17M	-$7.75M	-$10.29M	-$10.91M	-$13.91M	-$17.89M	-$15.21M
Financing cash flow	$30.84M	-$2.43M	-$1.43M	-$2.02M	-$4.06M	-$9.97M	-$2.05M	-$2.02M	-$1.91M	-$73.04M	-$50.88M	-$28.93M
Share buybacks	—	—	—	—	—	$0	$0	$0	—	$49.11M	$48.52M	$24.80M
Stock-based compensation	$20.92M	$20.58M	$24.55M	$14.89M	$16.15M	$18.58M	$21.12M	$18.30M	$16.70M	$15.20M	$19.75M	$18.17M
Depreciation & amortization	$9.67M	$10.02M	$10.13M	$10.41M	$10.12M	$10.29M	$10.64M	$10.34M	$10.35M	$10.37M	$11.31M	$12.05M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.